The U.S. retirement program receives a ‘C+’ quality, specialists say — even though it’s well worth $39 trillion. Here is why

The U.S. retirement program receives a ‘C+’ quality, specialists say — even though it’s well worth  trillion. Here is why


Essential Details
  • The U.S. retirement process was presented a C+ quality in 2021 in the Mercer CFA Institute World wide Pension Index. The state also rated 17th on the Natixis Financial commitment Managers 2021 International Retirement Index.
  • Nations this kind of as Iceland, Norway, the Netherlands, Switzerland, Denmark, Australia, Ireland and New Zealand obtained larger marks.
  • There are shortcomings in the U.S. technique, these types of as a absence of 401(k) entry, professionals say. But enhancements have been designed in the earlier 15 or so yrs.



Resource

China didn’t grab many headlines at Davos, but it’s the elephant in the room
Finance

China didn’t grab many headlines at Davos, but it’s the elephant in the room

Davos 2026 China didn’t grab many headlines at Davos, but it’s the elephant in the room Published Sun, Jan 25 20267:04 PM ESTUpdated 56 Min Ago Evelyn Cheng@in/evelyn-cheng-53b23624@chengevelyn WATCH LIVE Source

Read More
Energy stocks to watch as major winter storm rips through the U.S.
Finance

Energy stocks to watch as major winter storm rips through the U.S.

Winter storm Fern is projected to have a wide-ranging impact on energy and power production. Here are a few stocks and energy related industry groups to watch around this and future storms. Natural gas producers The price move in natural gas has been profound. A 70% jump in the commodity in fewer than two weeks is stuff […]

Read More
Stocks making the biggest moves midday: Fortinet, Moderna, Intel, Bausch Health & more
Finance

Stocks making the biggest moves midday: Fortinet, Moderna, Intel, Bausch Health & more

Check out the companies making headlines in midday trading. Fortinet — Shares jumped more than 7% after TD Cowen upgraded the cybersecurity stock to buy from hold, saying rising memory prices won’t hurt the company as much as some suspect. The firm’s $100 price target suggests 29% upside ahead. Bausch Health — The pharmaceutical stock […]

Read More